Lubberman F, Gelderblom H, Hamberg P, et al. A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs? ASCO Annual Meeting 2019, abstract 4564.
Management van T-DXd-geassocieerde ILD bij HER2-positieve gemetastaseerde borstkanker
sep 2023 | Borstkanker, ILD